246 related articles for article (PubMed ID: 21976245)
61. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
62. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE
Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
[TBL] [Abstract][Full Text] [Related]
63. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.
Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334
[TBL] [Abstract][Full Text] [Related]
64. Colonic graft-versus-host disease.
Ross WA; Couriel D
Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
[TBL] [Abstract][Full Text] [Related]
65. Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care.
Trunk AD; Guo M; Budvytyte L; Islam NS; Khera N; Hamilton BK; Amonoo HL
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432186. PubMed ID: 38754066
[TBL] [Abstract][Full Text] [Related]
66. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
Zeiser R; Blazar BR
Blood; 2016 Jun; 127(25):3117-26. PubMed ID: 26994149
[TBL] [Abstract][Full Text] [Related]
67. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.
Villarreal CD; Alanis JC; Pérez JC; Candiani JO
An Bras Dermatol; 2016; 91(3):336-43. PubMed ID: 27438202
[TBL] [Abstract][Full Text] [Related]
68. [Recent advances in pathophysiology, diagnosis and treatment of steroid-refractory graft-versus-host disease].
Toubai T; Torii Y
Rinsho Ketsueki; 2021; 62(11):1557-1566. PubMed ID: 34866077
[TBL] [Abstract][Full Text] [Related]
69. Pathogenesis and management of graft-versus-host disease.
Choi SW; Levine JE; Ferrara JL
Immunol Allergy Clin North Am; 2010 Feb; 30(1):75-101. PubMed ID: 20113888
[TBL] [Abstract][Full Text] [Related]
70. Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation.
Hamilton BK
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):228-235. PubMed ID: 30504315
[TBL] [Abstract][Full Text] [Related]
71. Plasma biomarkers in graft-versus-host disease: a new era?
Paczesny S; Levine JE; Braun TM; Ferrara JL
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):33-8. PubMed ID: 19147075
[TBL] [Abstract][Full Text] [Related]
72. How I treat chronic graft-versus-host disease.
Vogelsang GB
Blood; 2001 Mar; 97(5):1196-201. PubMed ID: 11222360
[TBL] [Abstract][Full Text] [Related]
73. Mechanistic approaches for the prevention and treatment of chronic GVHD.
Cutler CS; Koreth J; Ritz J
Blood; 2017 Jan; 129(1):22-29. PubMed ID: 27821505
[TBL] [Abstract][Full Text] [Related]
74. Noncoding RNAs in diagnosis and prognosis of graft-versus-host disease (GVHD).
Vajari MK; Moradinasab S; Yousefi AM; Bashash D
J Cell Physiol; 2022 Sep; 237(9):3480-3495. PubMed ID: 35842836
[TBL] [Abstract][Full Text] [Related]
75. Chronic graft-versus-host disease: Current management paradigm and future perspectives.
Mawardi H; Hashmi SK; Elad S; Aljurf M; Treister N
Oral Dis; 2019 May; 25(4):931-948. PubMed ID: 29984442
[TBL] [Abstract][Full Text] [Related]
76. Acute Graft-versus-Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment.
DiMaggio E
Pharmacotherapy; 2020 Aug; 40(8):788-807. PubMed ID: 32530080
[TBL] [Abstract][Full Text] [Related]
77. Current Advances in Graft-versus-host Disease After Intestinal Transplantation.
Oza K; Kang J; Patil D; Owen KL; Cui W; Khan K; Kaufman SS; Kroemer A
Transplantation; 2024 Feb; 108(2):399-408. PubMed ID: 37309025
[TBL] [Abstract][Full Text] [Related]
78. [Biomarkers of graft-versus-host disease following allogeneic hematopoietic cell transplantation].
Nakasone H
Rinsho Ketsueki; 2020; 61(4):379-386. PubMed ID: 32378584
[TBL] [Abstract][Full Text] [Related]
79. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.
Blanchard SK; Sullivan KM; Hooten JN; Holcomb ZE; Rowe Nichols K; Selim MA; Rao CL; Hall RP; Chao NJ; Cardones AR
Br J Dermatol; 2019 Oct; 181(4):869-871. PubMed ID: 31017659
[No Abstract] [Full Text] [Related]
80. "Phage Transplantation in Allotransplantation": Possible Treatment in Graft-Versus-Host Disease?
Górski A; Jończyk-Matysiak E; Międzybrodzki R; Weber-Dąbrowska B; Borysowski J
Front Immunol; 2018; 9():941. PubMed ID: 29755481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
